Securities allotted from Block Listing

RNS Number : 0411I

The MedicX Fund Limited

16 March 2018

 

For immediate release

16 March 2018

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Securities allotted from Block Listing

MedicX Fund Limited (LSE: MXF), announces in accordance with Listing Rule 3.5.6R the number of securities allotted over the six month period pursuant to the block listing of 14,771,668 ordinary shares of no par value admitted to The Official List of the UK Listing Authority on 14 August 2017.

Name of applicant:		MedicX Fund Limited
Name of scheme:		Block Listing
Period of return:	From:	19/09/2017	To:	16/03/2018
Balance of unallotted securities under scheme(s) from previous return:		14,771,668
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		Total allotted - Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		Total remaining - 14,771,668

Name of contact:	Alan Pennell
Telephone number of contact:	0203 142 4813

- End -

For further information please contact:

Octopus Healthcare Adviser Limited                                  [phone]

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Canaccord Genuity                                                          [phone]

Andrew Zychowski/Helen Goldsmith        

Buchanan                                                                      [phone]

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 153 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over £1.2 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages £7 billion of funds for more than 50,000 retail and institutional investors as well as supplying energy to more than 100,000 customers

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25

 

END

 

 

BLRFMGMFKVKGRZM